Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calfar-Plus
- Development stage
- Unknown
- Lead developer
- Globus Remedies
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Calfar-Plus is a branded generic oral supplement manufactured by Globus Remedies, an Indian pharmaceutical company. It is a combination product containing **ferrous ascorbate**, **folic acid**, and **zinc sulphate**. Calfar-Plus is primarily indicated as a haematinic for the treatment and prevention of iron-deficiency anemia and associated nutritional deficiencies, particularly during pregnancy, lactation, and post-operative recovery. Ferrous ascorbate provides a highly bioavailable form of iron to support hemoglobin synthesis, while folic acid is essential for erythropoiesis and the prevention of neural tube defects. Zinc is included to support immune function and serve as a cofactor for numerous enzymatic processes.
- Brand names
- Calfar-Plus
- Other names
- Calfar Plus
Beyond the preview
Go deeper on Calfar-Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calfar-Plus.